Evidence map›Paper›PMID 29113609›Full record

ArticleParasitology2018

Dermotropic Leishmania donovani in Sri Lanka: visceralizing potential in clinical and preclinical studies.

K K G D U L Kariyawasam, A Selvapandiyan, H V Y D Siriwardana, A Dube, P Karunanayake, S A S C Senanayake, R Dey, S Gannavaram, H L Nakhasi, N D Karunaweera

Abstract read
In one paragraph

Article in Parasitology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Diagnostic Tools for Cutaneous Leishmaniasis Caused byDiagnostics (Basel, Switzerland) · 2023
    Review
  3. Review
  4. Article
  5. Assessment of Risk of Exposure toPathogens (Basel, Switzerland) · 2022
    Article
  6. Experimental Hybridization inPathogens (Basel, Switzerland) · 2022
    Review
  7. Article
  8. Review
  9. Detection ofJournal of tropical medicine · 2021
    Article
  10. Article
  11. Review
  12. Article
  13. Journal of tropical medicine · 2019
    Article
  14. Trends in Recently EmergedBioMed research international · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

K K G D U L KariyawasamDepartment of Parasitology,Faculty of Medicine,University of Colombo,No. 25,Kynsey Road,Colombo 8,Sri Lanka.ORCID 0000-0002-2226-9399
A SelvapandiyanJH-Institute of Molecular Medicine,Jamia Hamdard,New Delhi,India.
H V Y D SiriwardanaDepartment of Parasitology,Faculty of Medicine,University of Colombo,No. 25,Kynsey Road,Colombo 8,Sri Lanka.
A DubeCentral Drug Research Institute,Sector 10,Jankipuram Extension,Sitapur Road,Lucknow,Uttar Pradesh 226031,India.
P KarunanayakeDepartment of Clinical Medicine, Faculty of Medicine,University of Colombo,No. 25,Kynsey Road,Colombo 8,Sri Lanka.
S A S C SenanayakeDepartment of Parasitology,Faculty of Medicine,University of Colombo,No. 25,Kynsey Road,Colombo 8,Sri Lanka.
R DeyLaboratory of Emerging Pathogens,Division of Emerging and Transfusion Transmitted Diseases,Center for Biologics Evaluation and Research,Food and Drug Administration,Silver Spring, MD,USA.
S GannavaramLaboratory of Emerging Pathogens,Division of Emerging and Transfusion Transmitted Diseases,Center for Biologics Evaluation and Research,Food and Drug Administration,Silver Spring, MD,USA.
H L NakhasiLaboratory of Emerging Pathogens,Division of Emerging and Transfusion Transmitted Diseases,Center for Biologics Evaluation and Research,Food and Drug Administration,Silver Spring, MD,USA.
N D KarunaweeraDepartment of Parasitology,Faculty of Medicine,University of Colombo,No. 25,Kynsey Road,Colombo 8,Sri Lanka.

Funding

Epidemiology and transmission of Leishmania donovani infections in Sri Lanka and BhutanU01AI136033 · NIAID · UNIVERSITY OF COLOMBO · PI KARUNAWEERA, NADIRA DHARSHANI, ZHOU, GUOFA · 2017 to 2021
$2.0M
Study of cutaneous leishmaniasis in Sri Lanka caused by L.donovaniR01AI099602 · NIAID · UNIVERSITY OF COLOMBO · PI KARUNAWEERA, NADIRA DHARSHANI · 2012 to 2016
$635k
NIAID NIH HHS R01 AI099602NIAID NIH HHS U01 AI136033
6 · The paper itself

Abstract

The visceralizing potential of apparently dermotropic Leishmania donovani in Sri Lanka (L. donovani-SL) was investigated through long-term follow-up of cutaneous leishmaniasis (CL) patients and in vivo and in vitro experimental infection models. CL patients (n = 250) treated effectively with intra-lesional antimony therapy were followed-up six monthly for 4 years. There was no clinical evidence of visceralization of infection (VL) during this period. Infection of BALB/c mice with L. donovani-SL (test) through intra-dermal route led to the development of cutaneous lesions at the site of inoculation with no signs of systemic dissemination, in contrast to the observations made in animals similarly infected with a visceralizing strain of L. donovani-1S (control). Cytokine (IL-10, IFN-γ) release patterns of splenocytes and lymph node cell cultures derived from mice primed with experimental infections (with either test or control parasites) revealed significantly high IFN-γ response associated with test mice with CL, while prominent IL-10 levels were observed in association with control mice with VL. Furthermore, diminished infection efficiency, intracellular growth and survival of L. donovani-SL parasites compared with L. donovani-1S were evident through in vitro macrophage infection experiments. These studies confirm, for the first time, the essential dermotropic nature of L. donovani-SL suggesting natural attenuation of virulence of local parasite strains.

Indexed as

AdolescentAdultAgedAnimalsAntimonyChildChild, PreschoolClinical Studies as TopicCytokinesFollow-Up StudiesHumansInfantInterferon-gammaInterleukin-10Leishmania donovaniLeishmaniasis, CutaneousAntimonyCytokinesInterferon-gammaInterleukin-10animal modelscytokinesLeishmaniasispatient follow-upskin lesionsvirulence

Identifiers

PMID29113609
PMCPMC5989320

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.